Literature DB >> 19827012

The simultaneous use of weighted logrank and weighted Kaplan-Meier statistics with clustered right-censored data.

Yunchan Chi1, Pei-Fang Su.   

Abstract

Clustered right-censored data often arise from tumorigenicity experiments and clinical trials. For testing the equality of two survival functions, Jung and Jeong extended weighted logrank (WLR) tests to two independent samples of clustered right-censored data, while the weighted Kaplan-Meier (WKM) test can be derived from the work of O'Gorman and Akritas. The weight functions in both classes of tests (WLR and WKM) can be selected to be more sensitive to detect a certain alternative; however, since the exact alternative is unknown, it is difficult to specify the selected weights in advance. Since WLR is rank-based, it is not sensitive to the magnitude of the difference in survival times. Although WKM is constructed to be more sensitive to the magnitude of the difference in survival times, it is not sensitive to late hazard differences. Therefore, in order to combine the advantages of these two classes of tests, this paper developed a class of versatile tests based on simultaneously using WLR and WKM for two independent samples of clustered right-censored data. The comparative results from a simulation study are presented and the implementation of the versatile tests to two real data sets is illustrated.

Mesh:

Substances:

Year:  2010        PMID: 19827012     DOI: 10.1002/sim.3746

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Sample size determination for paired right-censored data based on the difference of Kaplan-Meier estimates.

Authors:  Pei-Fang Su; Chung-I Li; Yu Shyr
Journal:  Comput Stat Data Anal       Date:  2014-06-01       Impact factor: 1.681

2.  Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.

Authors:  Lihui Zhao; Lu Tian; Hajime Uno; Scott D Solomon; Marc A Pfeffer; Jerald S Schindler; Lee Jen Wei
Journal:  Clin Trials       Date:  2012-08-22       Impact factor: 2.486

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.